Curriculum Vitae Michalis (Michael) V. Karamouzis - MyLoyalCard

east diagnosed with gray-level and color doppler ultrasonography", J Clin Ultr,
30(9): 552-556, 2002.
10) A.G. Papatsoris, F.A. Mpadra, M.V. Karamouzis & C.Y. Frangides: "Bruccelar
orcheoepididimytis in Western Greece: ten years experience", Int J Infect Dis,
6(4): 309-313, 2002.
11) A.G. Papatsoris, F.A. Badra & M.V. Karamouzis: "Post-traumatic testicular
torsion". Ulus Trauma Derg, 9(1): 70-71, 2003.
12) E.G. Solomou, G. Patriarheas, F.A. Mpadra, M.V. Karamouzis & I. Dimopoulos:
"Asymptomatic adult cystic lymphangioma of the spleen: Case report and review
of the literature". Magn Reson Imaging, 21: 81-84, 2003.
13) A.G. Papatsoris, F.A. Badra, M.V. Karamouzis, E. Likaki-Karatza & T. Karatzas:
"Torsion of undescended testis in an adult with Down's syndrome". Int J Urology,
10: 233-235, 2003.
14) M.V. Karamouzis, M. Melachrinou, M. Fratzoglou, Ch Labropoulou-Karatza &
H.P. Kalofonos: "Hepatocellular carcinoma metastasis in the pituitary gland: case
report and review of the literature", J Neuro-Oncology, 63(2): 173-177, 2003.
15) M.V. Karamouzis, F.A. Badra & A.G. Papatsoris: "A case of colonic ischemia
mimicking carcinoma". Int J Gastrointestinal Cancer, 32(2-3): 165-168, 2003.
16) M.V. Karamouzis, G. Sotiropoulou-Bonikou, G. Vandoros, I. Varakis & A.G.
Papavassiliou: “Retinoid-X-receptor alpha (RXRα) expression during laryngeal
carcinogenesis: Detrimental or beneficial event?”. Cancer Lett, 199(2): 175-183,
2003.
17) Α. Alexopoulos, D. Tryfonopoulos, M.V. Karamouzis, G. Gerasimidis, I. Karydas,
K. Kandilis, J. Stavrakakis, H. Stavrinides, C. Georganta, A. Ardavanis & G.
Rigatos: “Evidence for In Vivo Synergism between Docetaxel and Gemcitabine in
Patients with Metastatic Breast Cancer”. Ann Oncol, 15: 88-94, 2004.
18) M.V. Karamouzis, G. Sotiropoulou-Bonikou, G. Vandoros, I. Varakis & A.G.
Papavassiliou: “Differential expression of retinoic acid receptor beta (RARβ) and
AP-1 transcription factor in normal, premalignant and malignant human laryngeal
tissues”. Eur J Cancer, 40: 761-773, 2004.
19) M.V Karamouzis & A.G. Papavassiliou: “COX-2 inhibition in cancer
therapeutics: a field of controversy or a magic bullet?”. Expert Opin Invest Drugs,
13: 359-372, 2004.
3
3